Results 91 to 100 of about 11,471 (211)
Toxic Epidermal Necrolysis-like Cutaneous Lupus Erythematosus: A Series of Three Patients
Toxic epidermal necrolysis-like lesions have been described in the setting of lupus erythematosus, and have been considered as a specific hyperacute variant of cutaneous lupus erythematosus, with features different from classical drug-related toxic ...
VALENTE, Neusa Y. S. +11 more
core +1 more source
BRAF inhibitors and MEK inhibitors (MEKi) have reshaped the treatment of BRAFV600‐mutant malignancies; however, cutaneous adverse drug reactions (ADRs) remain a frequent and clinically impactful toxicity. Although clinical trials provide insight into their safety profiles, real‐world data on dermatologic ADRs are limited.
Natalia Sauer +3 more
wiley +1 more source
Pediatric SJS-TEN: Where are we now? [version 1; peer review: 2 approved]
Stevens–Johnson syndrome and toxic epidermal necrolysis are rare severe blistering skin reactions triggered by medications or infections. Over the last 5 to 10 years, a number of important publications have advanced understanding of these diseases and ...
Michele Ramien, Jennifer L. Goldman
doaj +1 more source
European S2k guidelines on management of autoimmune blistering diseases in children and adolescents
Autoimmune blistering disorders (AIBDs) in children are rare, challenging to diagnose and treat and often require immunosuppressants. Until now, no paediatric care guidelines existed. The EADV Task Force for AIBDs has developed the consensus‐based recommendations, enabling physicians to adopt a uniform, tailored treatment strategy to improve outcomes ...
A. Nanda +31 more
wiley +1 more source
Toxic epidermal necrolysis caused by flurazepam?
Stevens-Johnson syndrome and toxic epidermal necrolysis are rare, but severe cutaneous reactions. Beside cutaneous manifestations, the syndrome is characterised by constitutional sypmtoms with even lethal consequences.
Bilusić, Marijo +2 more
core
Clinical Images: Skin manifestations and radiographic findings of anti‐SAE1 positive dermatomyositis
ACR Open Rheumatology, Volume 8, Issue 7, July 2026.
Amara Seng +4 more
wiley +1 more source
Given the lack of established practice guidelines for the management of cutaneous symptoms associated with toxic epidermal necrolysis, treatments range from various dressings to skin substitutes.
Isabella Lipkin +2 more
doaj +1 more source
Toxic epidermal necrolysis represents an immunologic reaction to a foreign antigen and is most often caused by drugs. Atorvastatin, a blood cholesterol–lowering agent, is a recognized cause of rhabdomyolysis; while naproxen, a widely used nonsteroidal ...
Sheik Oaleed Noordally +5 more
doaj +1 more source
Progression of Toxic Epidermal Necrolysis After Tanning Bed Exposure
Background: In addition to recreational tanning bed use, UV radiation exposures are sometimes sought to self-treat skin conditions. The ability of tanning bed radiation exposure to trigger toxic epidermal necrolysis has not been reported.
Gatson, Na Tosha +11 more
core +1 more source

